This inventor holds 1 USPTO granted patent. Top assignee: Amgen Fremont Inc.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Gerardo Zapata: Innovator in Antibody Technology
Introduction
Gerardo Zapata is a notable inventor based in San Mateo, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies.
Latest Patents
Zapata holds a patent for "Anti-properdin antibodies, and methods for making and using same." This invention relates to antibodies directed to the antigen properdin and their various applications. The patent provides fully human monoclonal antibodies aimed at the antigen properdin, along with nucleotide sequences encoding and polypeptides comprising heavy and light chain immunoglobulin molecules. These sequences span the framework regions and complementarity determining regions (CDRs), specifically from FR1 through FR4 or CDR1 through CDR3. Additionally, the patent includes hybridomas or other cell lines that express these immunoglobulin molecules and monoclonal antibodies.
Career Highlights
Gerardo Zapata is currently associated with Amgen Fremont Inc., where he continues to advance his research and development efforts in antibody technology. His work has the potential to impact various therapeutic applications.
Collaborations
Zapata has collaborated with notable colleagues such as Giorgio Senaldi and Gadi Gazit-Bornstein, contributing to the advancement of innovative solutions in biotechnology.
Conclusion
Gerardo Zapata's work in developing anti-properdin antibodies showcases his commitment to innovation in the field of biotechnology. His contributions are paving the way for new therapeutic possibilities.